About Nimoli Pharmaceuticals (P) Ltd.
Data last updated:
Nimoli Pharmaceuticals (P) Ltd. is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 August 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1998PTC361925. Its GSTIN is 07AAACN9402G1ZN (Delhi).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹26 Lakh. It was formerly known as Nimoli Pharmaceuticals Private Limited. It is led by directors including Vimla Sharma and Vinod Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 301 Blk. Pkt. E Lsc Vikas Puri Near Dusshera Ground, New, Delhi, India – 110018.
As per the financials filed for FY 2022, the company reported a revenue of ₹4.32 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹3.28 Lakh (net margin 0.8%) and EBITDA of ₹10.38 Lakh (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nimoli Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹1.11 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nimolipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit 301 Blk. Pkt. E Lsc Vikas Puri Near Dusshera Ground, New, Delhi, India – 110018
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Nimoli Pharmaceuticals (P) Ltd. FY 2025 filings available
Nimoli Pharmaceuticals (P) Ltd. reported revenue of ₹4.32 Cr (up 12% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Nimoli Pharmaceuticals (P) Ltd.
Revenue rose 12% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nimoli Pharmaceuticals (P) Ltd.
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.32 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.38 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.28 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nimoli Pharmaceuticals (P) Ltd.
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nimoli Pharmaceuticals (P) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) Ltd. is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anexas Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Agra, Uttar Pradesh, India |
| C.N. Medical Research Private Limited | •••• | •••• | •••• | •••• | - | Kanpur, Uttar Pradesh, India |
| Canviko Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| Well Life Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| Aaroohee Healthcare Private Limited | •••• | •••• | •••• | •••• | 37 | Jaipur, Rajasthan, India |
| Nimoli Pharmaceuticals (P) Ltd. this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Sandika Pharmaceuticals Private Ltd. | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Oxygen Remedies Private Limited | •••• | •••• | •••• | •••• | - | Kanpur, Uttar Pradesh, India |
| Zantic Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Vikasnagar, Uttarakhand, India |
| Trevo India Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Shanguide Pharmaceuticals India Private Limited | •••• | •••• | •••• | •••• | - | Vellore, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Nimoli Pharmaceuticals (P) by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) Ltd. is audited by SHARMA INDER & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHARMA INDER & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimla Sharma | Director | 16 Aug 2005 | 21 Years 1 Months | Current |
| Vinod Kumar Sharma | Director | 04 Aug 1998 | 28 Years 2 Months | Current |
| Sudesh Bansal | Director | 16 Aug 2005 | 21 Years 1 Months | Current |
Ownership and Shareholding of Nimoli Pharmaceuticals (P) Ltd.
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nimoli Pharmaceuticals (P) Ltd.
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2017 | Axis Bank Limited | ₹75 Lakh | Satisfied |
| 13 Jan 2011 | Icici Bank Limited | ₹35.5 Lakh | Satisfied |
Total charge records: 2 View all charges
Associated Brands with Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) operates one associated brand: Nimoli Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic tablets, capsules, syrup, and injectables | nimolipharma.com |
Employees and EPFO Compliance at Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) Ltd. has a workforce of 22 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) has one previous CIN (Corporate Identification Number): U24232HR1998PTC033999. The current CIN is U24232DL1998PTC361925, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL1998PTC361925 | Current |
| U24232HR1998PTC033999 | Previous |
Recent Activity on Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) Ltd. has 5 board changes on record since 1998: 4 appointments and 1 cessation. The latest: Kulbhushan Bansal ceased to be Director on 04 Oct 2016.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nimoli Pharmaceuticals (P) Ltd.
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nimoli Pharmaceuticals (P) Ltd.
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nimoli Pharmaceuticals (P) Ltd.
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACN9402G1ZN | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nimoli Pharmaceuticals (P) Ltd.
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nimoli Pharmaceuticals (P) Ltd.
Nimoli Pharmaceuticals (P) is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 August 1998 (28+ years old) and is registered under CIN U24232DL1998PTC361925.
Nimoli Pharmaceuticals (P) reported revenue of ₹4.32 Cr for FY 2022 (up 12% YoY).
Nimoli Pharmaceuticals (P) has 3 current directors:
- Vimla Sharma - Director
- Vinod Kumar Sharma - Director
- Sudesh Bansal - Director
Nimoli Pharmaceuticals (P) reported a net profit of ₹3.28 Lakh (net margin 0.8%) and EBITDA of ₹10.38 Lakh (EBITDA margin 2.4%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nimoli Pharmaceuticals (P) is -3% over five years. In the latest year (FY 2022) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nimoli Pharmaceuticals (P) is 07AAACN9402G1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Nimoli Pharmaceuticals (P) is U24232DL1998PTC361925. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nimoli Pharmaceuticals (P) was incorporated on 04 August 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nimoli Pharmaceuticals (P) by revenue are Anexas Pharmaceuticals Private Limited, C.N. Medical Research Private Limited, Canviko Healthcare Private Limited, Well Life Pharmaceuticals Private Limited, Aaroohee Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Kulbhushan Bansal ceased to be Director on 04 Oct 2016. Sudesh Bansal was appointed as Director on 16 Aug 2005. Vimla Sharma was appointed as Director on 16 Aug 2005. Nimoli Pharmaceuticals (P) has 5 board changes on record in total.
Nimoli Pharmaceuticals (P) can be reached through the website nimolipharma.com. Its registered office is in New, Delhi, India.